FDA Inspection 951274 — Innovative Transfusion Medicine, Inc.

Innovative Transfusion Medicine, Inc. — FEI 3000207042

The FDA completed an inspection of Innovative Transfusion Medicine, Inc. on Dec 8, 2015 in Miami Lakes, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 8, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami Lakes, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.